PCVX logo

Vaxcyte (PCVX) Selling, general & administrative expenses

annual SGA:

$92.90M+$32.20M(+53.05%)
December 31, 2024

Summary

  • As of today (July 3, 2025), PCVX annual SGA is $92.90 million, with the most recent change of +$32.20 million (+53.05%) on December 31, 2024.
  • During the last 3 years, PCVX annual SGA has risen by +$67.64 million (+267.80%).
  • PCVX annual SGA is now at all-time high.

Performance

PCVX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

quarterly SGA:

$32.66M+$4.10M(+14.37%)
March 31, 2025

Summary

  • As of today (July 3, 2025), PCVX quarterly SGA is $32.66 million, with the most recent change of +$4.10 million (+14.37%) on March 31, 2025.
  • Over the past year, PCVX quarterly SGA has increased by +$12.77 million (+64.24%).
  • PCVX quarterly SGA is now at all-time high.

Performance

PCVX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

TTM SGA:

-$5.32B-$509.63M(-10.60%)
March 31, 2025

Summary

  • As of today (July 3, 2025), PCVX TTM SGA is -$5.32 billion, with the most recent change of -$509.63 million (-10.60%) on March 31, 2025.
  • Over the past year, PCVX TTM SGA has dropped by -$5.38 billion (-7979.88%).
  • PCVX TTM SGA is now -4762.24% below its all-time high of -$109.35 million.

Performance

PCVX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

PCVX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+53.0%+64.2%-7979.9%
3 y3 years+267.8%+333.0%-10000.0%
5 y5 years+987.1%+895.4%-10000.0%

PCVX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+267.8%at high+246.8%-311.4%at low
5 y5-yearat high+987.1%at high+972.2%-1220.5%at low
alltimeall timeat high+1624.2%at high+2381.7%-4762.2%at low

PCVX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$32.66M(+14.4%)
$105.68M(+13.7%)
Dec 2024
$92.90M(+53.1%)
$28.55M(+24.2%)
$92.90M(+13.5%)
Sep 2024
-
$22.99M(+7.1%)
$81.87M(+9.9%)
Jun 2024
-
$21.47M(+8.0%)
$74.49M(+10.4%)
Mar 2024
-
$19.89M(+13.5%)
$67.47M(+11.2%)
Dec 2023
$60.70M(+52.5%)
$17.53M(+12.3%)
$60.70M(+10.1%)
Sep 2023
-
$15.61M(+7.9%)
$55.13M(+9.3%)
Jun 2023
-
$14.46M(+10.3%)
$50.42M(+11.1%)
Mar 2023
-
$13.11M(+9.7%)
$45.38M(+14.0%)
Dec 2022
$39.81M(+57.6%)
$11.95M(+9.7%)
$39.81M(+15.0%)
Sep 2022
-
$10.90M(+15.7%)
$34.63M(+14.5%)
Jun 2022
-
$9.42M(+24.8%)
$30.25M(+12.4%)
Mar 2022
-
$7.54M(+11.4%)
$26.92M(+6.6%)
DateAnnualQuarterlyTTM
Dec 2021
$25.26M(+57.7%)
$6.77M(+3.8%)
$25.26M(+8.5%)
Sep 2021
-
$6.52M(+7.3%)
$23.28M(+7.5%)
Jun 2021
-
$6.08M(+3.3%)
$21.65M(+16.3%)
Mar 2021
-
$5.88M(+22.8%)
$18.62M(+16.3%)
Dec 2020
$16.02M(+87.4%)
$4.79M(-2.2%)
$16.02M(+17.1%)
Sep 2020
-
$4.90M(+60.8%)
$13.68M(+21.1%)
Jun 2020
-
$3.05M(-7.2%)
$11.29M(+7.4%)
Mar 2020
-
$3.28M(+33.5%)
$10.51M(+23.0%)
Dec 2019
$8.55M(+58.6%)
$2.46M(-2.1%)
$8.55M(+40.3%)
Sep 2019
-
$2.51M(+10.9%)
$6.09M(+70.1%)
Jun 2019
-
$2.26M(+72.0%)
$3.58M(+172.0%)
Mar 2019
-
$1.32M
$1.32M
Dec 2018
$5.39M
-
-

FAQ

  • What is Vaxcyte annual SGA?
  • What is the all time high annual SGA for Vaxcyte?
  • What is Vaxcyte annual SGA year-on-year change?
  • What is Vaxcyte quarterly SGA?
  • What is the all time high quarterly SGA for Vaxcyte?
  • What is Vaxcyte quarterly SGA year-on-year change?
  • What is Vaxcyte TTM SGA?
  • What is the all time high TTM SGA for Vaxcyte?
  • What is Vaxcyte TTM SGA year-on-year change?

What is Vaxcyte annual SGA?

The current annual SGA of PCVX is $92.90M

What is the all time high annual SGA for Vaxcyte?

Vaxcyte all-time high annual SGA is $92.90M

What is Vaxcyte annual SGA year-on-year change?

Over the past year, PCVX annual SGA has changed by +$32.20M (+53.05%)

What is Vaxcyte quarterly SGA?

The current quarterly SGA of PCVX is $32.66M

What is the all time high quarterly SGA for Vaxcyte?

Vaxcyte all-time high quarterly SGA is $32.66M

What is Vaxcyte quarterly SGA year-on-year change?

Over the past year, PCVX quarterly SGA has changed by +$12.77M (+64.24%)

What is Vaxcyte TTM SGA?

The current TTM SGA of PCVX is -$5.32B

What is the all time high TTM SGA for Vaxcyte?

Vaxcyte all-time high TTM SGA is -$109.35M

What is Vaxcyte TTM SGA year-on-year change?

Over the past year, PCVX TTM SGA has changed by -$5.38B (-7979.88%)
On this page